News & Commentary on Prescription Drug & Medical Device Lawsuits
A man by the name of Sandeep Barot has filed a proposed consumer protection class-action lawsuit against the manufacturer and distributor of dietary supplements that allegedly cause liver damage. See Barot v. USPLabs LLC et al., No. 1:14-cv-00562, complaint filed (D.N.J. Feb. 3, 2014).
The defendant companies are USPLabs, LLC (“USPLabs”) and General Nutrition…
Though the diet supplement OxyElite Pro was recalled last year due to a connection with liver damage and acute liver failure, more people continue to get sick, according to a recent report by Scientific American.
Currently, at least 97 people have suffered severe hepatitis in connection with OxyElite Pro, and one person has died. …
Seizures are potentially dangerous episodes resulting from abnormal neuronal activity in the brain. Several medications have been created to prevent these episodes from occurring. One such Anti-seizure medication is called Onfi, which is a schedule IV (CIV) oral antiepileptic. Onfi has also been linked to some very harmful side effects, which has prompted the…
On October 11th, the US Centers for Disease Control and Prevention reported that 317 people have become sick across the country in a recent outbreak of salmonella “tied to a California poultry producer.” As reported by the American Association for Justice, “nearly half of the cases required hospitalization” and about three-quarters of the cases…
On October 11th, the US Centers for Disease Control and Prevention reported that 317 people have become sick across the country in a recent outbreak of salmonella “tied to a California poultry producer.” As reported by the American Association for Justice, “nearly half of the cases required hospitalization” and about three-quarters of the cases…
On August 21st, the US Food and Drug Administration issued a Class-1 recall for Siemens MicroScan Synergies plus® and MicroScan® rapID/S plus Negative Panels, affecting “78,020 panels distributed in the US between 07/11/2011 and 08/02/2013.” (FDA)
These panels come as part of kits used by medical professionals to test a patient’s saliva or tissue…
Cipro (ciprofloxacin), an antibiotic that has recently been linked to retinal detachment and other nerve disorders, came under fire last week as the US Food and Drug Administration rules that new warnings and usage guidelines be included on its packaging “to better describe the serious side effect of peripheral neuropathy”[1] or, nerve…
On August 1st, the FDA issued a safety alert for acetaminophen, the main ingredient in Tylenol and other painkillers, based on new data that has shown exposure to the drug can trigger several rare but dangerous skin reactions.
An excerpt from the FDA report:
“These skin reactions [associated with acetaminophen], known as Stevens-Johnson Syndrome…
WARNING: FDA TO INVESTIGATE VICTOZA-CANCER LINK
Recently, the FDA has moved to evaluate whether or not Victoza (liraglutide), a drug used in GLP-1 therapy for the treatment of type II diabetes is associated with an increased rate for cancer.
Victoza and other GLP-1 therapy drugs have been previously linked to asymptomatic pancreatitis, and…
I got an email from the FDA alerting me to new warnings about the usage of Avandia. Apparently, the FDA has not decided to withdraw Avandia, but is severely restricting who may use it:
FDA will require that GSK develop a restricted access program for Avandia under a risk evaluation and mitigation strategy, or REMS.
…